Crossmark

Enhanced efficacy of radiofrequency ablation for hepatocellular carcinoma using a novel vascular disrupting agent, CKD-516

Crossref DOI link: https://doi.org/10.1007/s12072-017-9811-4

Published Online: 2017-07-18

Published Print: 2017-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ham, Su Jung

Choi, YoonSeok

Lee, Seul-I

Kim, Jinil

Kim, Young Il

Chung, Jin Wook

Kim, Kyung Won
Funding

Funding for this research was provided by:

Ministry of Health and Welfare (HI12C1148)

Seoul National University Hospital (04-2014-0720)
License Information

License valid from 2017-07-18